Cross-species functional transcriptomic analysis distinguishes conserved aging-niche remodeling from inflammatory fibroblast heterogeneity in cardiac aging and heart failure.
Y, L. (2026). Cross-species functional transcriptomic analysis distinguishes conserved aging-niche remodeling from inflammatory fibroblast heterogeneity in cardiac aging and heart failure.. Functional & integrative genomics. https://doi.org/10.1007/s10142-026-02001-z
Y L. Cross-species functional transcriptomic analysis distinguishes conserved aging-niche remodeling from inflammatory fibroblast heterogeneity in cardiac aging and heart failure.. Functional & integrative genomics. 2026; doi: 10.1007/s10142-026-02001-z
Y L. Cross-species functional transcriptomic analysis distinguishes conserved aging-niche remodeling from inflammatory fibroblast heterogeneity in cardiac aging and heart failure.[J]. Functional & integrative genomics. 2026. DOI: 10.1007/s10142-026-02001-z.
@article{y2026,
author = {Li Y},
title = {Cross-species functional transcriptomic analysis distinguishes conserved aging-niche remodeling from inflammatory fibroblast heterogeneity in cardiac aging and heart failure.},
journal = {Functional & integrative genomics},
year = {2026},
doi = {10.1007/s10142-026-02001-z},
note = {PMID: 42538413},
}
TY - JOUR AU - Li Y TI - Cross-species functional transcriptomic analysis distinguishes conserved aging-niche remodeling from inflammatory fibroblast heterogeneity in cardiac aging and heart failure. T2 - Functional & integrative genomics PY - 2026 DO - 10.1007/s10142-026-02001-z AN - PMID:42538413 ER -
Cardiac aging is accompanied by inflammatory and extracellular-matrix remodeling, but the extent to which aging-associated fibroblast programs are reproducibly altered in human heart failure remains unclear. We integrated mouse cardiac aging single-cell RNA sequencing, human cardiac aging resources, adult human cardiac fibroblast single-cell data, and two independent human left-ventricular heart-failure cohorts. Mouse fibroblast subclustering identified an old-enriched inflammatory/stress state (Fib0) that expanded from approximately 2.3% of fibroblasts in young mice to 33.4% in old mice. The same discovery-derived signatures were then applied without redefinition to human datasets. A conserved cardiac aging niche score (CCANS) was increased in both heart-failure cohorts and showed a positive random-effects standardized mean difference (Hedges g = 1.04, 95% CI 0.53 to 1.55; P = 6.32 × 10⁻⁵). In contrast, Fib0-marker and inflammatory-fibroblast scores showed marked between-cohort heterogeneity, precluding their interpretation as uniformly reactivated heart-failure states. Adult human heart fibroblast data localized Fib0-like activity to defined fibroblast states, and reanalysis of published IL-1β-stimulated human cardiac fibroblasts supported inducibility of the inflammatory/NF-κB/CEBP core. These findings support conserved remodeling of a cardiac aging niche program across heart failure while identifying context-dependent divergence of individual inflammatory fibroblast signatures.